1. Home
  2. ICUI vs AGX Comparison

ICUI vs AGX Comparison

Compare ICUI & AGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • AGX
  • Stock Information
  • Founded
  • ICUI 1984
  • AGX 1961
  • Country
  • ICUI United States
  • AGX United States
  • Employees
  • ICUI N/A
  • AGX N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • AGX Engineering & Construction
  • Sector
  • ICUI Health Care
  • AGX Consumer Discretionary
  • Exchange
  • ICUI Nasdaq
  • AGX Nasdaq
  • Market Cap
  • ICUI 3.0B
  • AGX 3.0B
  • IPO Year
  • ICUI 1992
  • AGX N/A
  • Fundamental
  • Price
  • ICUI $133.13
  • AGX $231.82
  • Analyst Decision
  • ICUI Buy
  • AGX Buy
  • Analyst Count
  • ICUI 6
  • AGX 3
  • Target Price
  • ICUI $186.60
  • AGX $210.00
  • AVG Volume (30 Days)
  • ICUI 314.3K
  • AGX 392.0K
  • Earning Date
  • ICUI 11-11-2025
  • AGX 09-04-2025
  • Dividend Yield
  • ICUI N/A
  • AGX 0.64%
  • EPS Growth
  • ICUI N/A
  • AGX 160.19
  • EPS
  • ICUI N/A
  • AGX 8.31
  • Revenue
  • ICUI $2,372,504,000.00
  • AGX $920,885,000.00
  • Revenue This Year
  • ICUI N/A
  • AGX $10.73
  • Revenue Next Year
  • ICUI N/A
  • AGX $24.59
  • P/E Ratio
  • ICUI N/A
  • AGX $27.99
  • Revenue Growth
  • ICUI 2.96
  • AGX 29.16
  • 52 Week Low
  • ICUI $107.00
  • AGX $86.98
  • 52 Week High
  • ICUI $196.26
  • AGX $253.79
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 60.24
  • AGX 53.73
  • Support Level
  • ICUI $121.61
  • AGX $202.25
  • Resistance Level
  • ICUI $136.61
  • AGX $235.49
  • Average True Range (ATR)
  • ICUI 3.76
  • AGX 11.63
  • MACD
  • ICUI 1.09
  • AGX 0.29
  • Stochastic Oscillator
  • ICUI 78.47
  • AGX 73.07

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About AGX Argan Inc.

Argan Inc is a United States-based construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC, and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Telecom Services, out of which Power Services derives the majority of revenue.

Share on Social Networks: